SCHEMBL12640336

SCHEMBL12640336

Cc1cc(Br)cnc1NCc1cncc(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
CYP2C9 P11712 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NPC1 O15118 2/20 0.41
PDPK1 O15530 1/20 0.36
DYRK1A Q13627 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
MEN1 O00255 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.35
KDR P35968 1/20 0.34
ADORA2B P29275 2/20 0.34
HTT P42858 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12675572 0.86 CYP2C9 (0.41) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL12640370 0.81 PDPK1 (0.37) ALDH1A1CYP2C9PDPK1DYRK1ACLK4
SCHEMBL12640333 0.76 CYP3A4 (0.46) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL12640326 0.74 NPC1 (0.50) ALDH1A1MAPTCYP2C9NPC1DYRK1A
SCHEMBL12640332 0.74 CYP3A4 (0.45) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL12640338 0.72 KDM4E (0.53) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL12640342 0.72 CYP2C9 (0.48) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL19260116 0.72 ALDH1A1 (0.40) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL10365802 0.71 ALDH1A1 (0.42) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6
SCHEMBL7751879 0.71 ALDH1A1 (0.40) ALDH1A1MAPTCYP2C9CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096593-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2015-08-04 US disclosed
US-9096593-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2015-08-04 US disclosed
US-20140045840-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2014-02-13 US disclosed
US-20140045840-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2014-02-13 US disclosed
WO-2011057022-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-05-12 WO disclosed
US-20110112127-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. 2011-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112127-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR KIT, FLT3, BRAF ALDH1A1 2981/4885MAPT 1276/4885CYP2C9 3884/4885
US-20140045840-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR KIT, FLT3, BRAF ALDH1A1 2981/4885MAPT 1276/4885CYP2C9 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.